Protein Expression Market to Reach $54 Billion by 2027
Rapid Growth Driven by Pharmaceutical and Biotechnology Industries
Market Overview
The global protein expression market, currently valued at $29 billion, is poised for significant growth in the coming years. This growth is largely attributed to the increasing demand for proteins in the pharmaceutical and biotechnology industries, where they are used in the development and production of therapeutic drugs and vaccines.
The pharmaceutical and biotechnology companies segment held a dominant share of the market in 2021, and this dominance is expected to continue throughout the forecast period. This segment's growth is driven by the increasing prevalence of chronic diseases and the rising demand for personalized treatments.
Market Drivers
Several factors are propelling the growth of the protein expression market:
- Rising demand for proteins in drug development
- Technological advancements in protein expression techniques
- Growing adoption of cell-free protein expression systems
Regional Outlook
North America holds the largest share of the protein expression market, followed by Europe and Asia-Pacific. However, the Asia-Pacific region is expected to experience significant growth over the forecast period due to the increasing number of pharmaceutical and biotechnology companies in the region.
Key Players
Major players in the protein expression market include:
- Charles River Laboratories
- Lonza
- Thermo Fisher Scientific
- MilliporeSigma
- JSR Corporation
Conclusion
The protein expression market is poised for robust growth in the coming years. The increasing demand for proteins in the pharmaceutical and biotechnology industries, coupled with technological advancements and the growing adoption of cell-free protein expression systems, will drive market expansion. Players in this market are well-positioned to capitalize on this growth by investing in innovative technologies and expanding their geographical reach.
Komentar